v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 80 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
OPERATING EXPENSES      
Research and development $ 265,035 $ 374,855 $ 23,608,340
General and administrative 551,741 536,255 13,327,775
Total Operating Expenses 816,776 911,110 36,936,115
LOSS FROM OPERATIONS (816,776) (911,110) (36,936,115)
OTHER INCOME (EXPENSE)      
Other income, net 0 0 420,987
Interest income 128 949 126,435
Interest expense, including amortization and write-off of deferred financing costs and debt discounts (440,403) 0 (12,016,367)
LOSS BEFORE INCOME TAXES (1,257,051) (910,161) (48,405,060)
State income tax benefit 0 0 774,775
NET LOSS (1,257,051) (910,161) (47,630,285)
Deemed dividend - beneficial conversion feature (180,502) 0 (180,502)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (1,437,553) $ (910,161) $ (47,810,787)
NET LOSS PER SHARE - BASIC AND DILUTED $ (0.12) $ (0.08)  
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED 11,603,184 11,408,274